Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | LY96 |
| Upstream (Parents) |
|---|
| (<<) TYROBP → LY96 |
| (<<) HLA-DRA → LY96 |
| (<<) CD86 → LY96 |
| (<<) RNASE6 → LY96 |
| Downstream (Children) |
|---|
| LY96 → C7orf13 (>>) |
| LY96 → RIPK4 (>>) |
| LY96 → EIF3CL///EIF3C (>>) |
| LY96 → MICAL3 (>>) |
| LY96 → PECAM1 (>>) |
| LY96 → ARL11 (>>) |
| LY96 → SAT1 (>>) |
| LY96 → C6orf168 (>>) |
| LY96 → FCGR2B (>>) |
| LY96 → TRIM45 (>>) |
| LY96 → VANGL1 (>>) |
| LY96 → CELSR2 (>>) |
| LY96 → CCPG1 (>>) |
| LY96 → ENTPD1 (>>) |
| LY96 → EMP3 (>>) |
